Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins

Author(s): Marta Karazniewicz-Lada, Anna  Glowka, Jakub Mikolajewski, Juliusz Przyslawski

Journal Name: Current Drug Metabolism

Volume 17 , Issue 9 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Statins are cholesterol-lowering agents which belong to the group of the most commonly prescribed drugs. The use of statins has become the standard treatment in patients with an increased risk of cardiovascular and coronary heart diseases. However, many clinical studies have shown that 13 - 75% of patients fail to achieve LDL-cholesterol and total cholesterol target levels. The clinical implications of insufficient response include cardiovascular complications caused by atherosclerosis leading to acute myocardial infarction, stroke and death. The mechanism underlying statin resistance has been associated with genetic polymorphisms and nongenetic factors (e.g. concomitant diseases, drug-drug interactions, interactions with food and dietary supplements). The article provides a comprehensive update of the current knowledge regarding the role of genetic polymorphism and non-genetic determinants of cholesterol-lowering effect of statins. Dietary aspects of statin efficacy were also presented. The Pubmed search was performed to identify relevant papers from the last ten years which were included in the review. Consideration of the genetic and non-genetic determinants of pharmacological action of statins as well as mechanisms of drug-drug interactions may be useful in clinical practice for improving safety and efficacy of statin treatment.

Keywords: Cholesterol-lowering agents, CYP450 polymorphism, dietary modulators, drug-drug interactions, pharmacogenetics, resistance to statin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 20 October, 2016
Page: [877 - 896]
Pages: 20
DOI: 10.2174/1389200217666160919104241
Price: $65

Article Metrics

PDF: 55
PRC: 1